These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 27402168)

  • 21. Beyond BRCA1 and BRCA2.
    King-Spohn K; Pilarski R
    Curr Probl Cancer; 2014; 38(6):235-48. PubMed ID: 25497410
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of targeted BRCA1/BRCA2 mutation analysis in hereditary breast/ovarian cancer families of Portuguese ancestry.
    Peixoto A; Santos C; Pinto P; Pinheiro M; Rocha P; Pinto C; Bizarro S; Veiga I; Principe AS; Maia S; Castro F; Couto R; Gouveia A; Teixeira MR
    Clin Genet; 2015 Jul; 88(1):41-8. PubMed ID: 24916970
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Underdiagnosis of Hereditary Breast and Ovarian Cancer in Medicare Patients: Genetic Testing Criteria Miss the Mark.
    Yang S; Axilbund JE; O'Leary E; Michalski ST; Evans R; Lincoln SE; Esplin ED; Nussbaum RL
    Ann Surg Oncol; 2018 Oct; 25(10):2925-2931. PubMed ID: 29998407
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Factors associated with genetic counseling and BRCA testing in a population-based sample of young Black women with breast cancer.
    Cragun D; Bonner D; Kim J; Akbari MR; Narod SA; Gomez-Fuego A; Garcia JD; Vadaparampil ST; Pal T
    Breast Cancer Res Treat; 2015 May; 151(1):169-76. PubMed ID: 25868867
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic and clinical characteristics in Japanese hereditary breast and ovarian cancer: first report after establishment of HBOC registration system in Japan.
    Arai M; Yokoyama S; Watanabe C; Yoshida R; Kita M; Okawa M; Sakurai A; Sekine M; Yotsumoto J; Nomura H; Akama Y; Inuzuka M; Nomizu T; Enomoto T; Nakamura S
    J Hum Genet; 2018 Apr; 63(4):447-457. PubMed ID: 29176636
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Satisfaction with genetic counseling for BRCA1 and BRCA2 mutations among African American women.
    Charles S; Kessler L; Stopfer JE; Domchek S; Halbert CH
    Patient Educ Couns; 2006 Oct; 63(1-2):196-204. PubMed ID: 16533589
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Psychosocial outcomes and counselee satisfaction following genetic counseling for hereditary breast and ovarian cancer: A patient-reported outcome study.
    Oberguggenberger A; Sztankay M; Morscher RJ; Sperner-Unterweger B; Weber I; Hubalek M; Kemmler G; Zschocke J; Martini C; Egle D; Dünser M; Gamper E; Meraner V
    J Psychosom Res; 2016 Oct; 89():39-45. PubMed ID: 27663109
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Psychosocial impact of BRCA testing in young Black breast cancer survivors.
    Gonzalez BD; Hoogland AI; Kasting ML; Cragun D; Kim J; Ashing K; Holt CL; Hughes Halbert C; Pal T; Vadaparampil ST
    Psychooncology; 2018 Dec; 27(12):2778-2785. PubMed ID: 30207419
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of a computer-based decision aid on knowledge, perceptions, and intentions about genetic testing for breast cancer susceptibility: a randomized controlled trial.
    Green MJ; Peterson SK; Baker MW; Harper GR; Friedman LC; Rubinstein WS; Mauger DT
    JAMA; 2004 Jul; 292(4):442-52. PubMed ID: 15280342
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tracking the dissemination of a culturally targeted brochure to promote awareness of hereditary breast and ovarian cancer among Black women.
    Scherr CL; Bomboka L; Nelson A; Pal T; Vadaparampil ST
    Patient Educ Couns; 2017 May; 100(5):805-811. PubMed ID: 27866793
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence of hereditary breast and ovarian cancer (HBOC) predisposition gene mutations among 882 HBOC high-risk Chinese individuals.
    Shao D; Cheng S; Guo F; Zhu C; Yuan Y; Hu K; Wang Z; Meng X; Jin X; Xiong Y; Chai X; Li H; Zhang Y; Zhang H; Liu J; Ye M
    Cancer Sci; 2020 Feb; 111(2):647-657. PubMed ID: 31742824
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Comparison of hereditary breast and ovarian cancer syndrome and sporadic ovarian cancer in ovarian cancer BRCA mutations].
    Duan RR; Sun LX; Zhao HW
    Zhonghua Fu Chan Ke Za Zhi; 2021 Nov; 56(11):788-795. PubMed ID: 34823292
    [No Abstract]   [Full Text] [Related]  

  • 33. Health Care Disparities in Hereditary Ovarian Cancer: Are We Reaching the Underserved Population?
    Randall TC; Armstrong K
    Curr Treat Options Oncol; 2016 Aug; 17(8):39. PubMed ID: 27315065
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intentions for risk-reducing surgery among high-risk women referred for BRCA1/BRCA2 genetic counseling.
    Tong A; Kelly S; Nusbaum R; Graves K; Peshkin BN; Valdimarsdottir HB; Wood M; McKinnon W; Garber J; McCormick SR; Jandorf L; Schwartz MD
    Psychooncology; 2015 Jan; 24(1):33-9. PubMed ID: 24839250
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Issues of concern in risk assessment, genetic counseling, and genetic testing of younger breast cancer patients in Japan.
    Bando H
    Breast Cancer; 2014 Nov; 21(6):656-63. PubMed ID: 23754181
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prediction of Cancer Prevention: From Mammogram Screening to Identification of BRCA1/2 Mutation Carriers in Underserved Populations.
    Robinson LS; Hendrix A; Xie XJ; Yan J; Pirzadeh-Miller S; Pritzlaff M; Read P; Pass S; Euhus D; Ross TS
    EBioMedicine; 2015 Nov; 2(11):1827-33. PubMed ID: 26870808
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence of mutations in BRCA and MMR genes in patients affected with hereditary endometrial cancer.
    Vietri MT; D'Elia G; Caliendo G; Casamassimi A; Federico A; Passariello L; Cioffi M; Molinari AM
    Med Oncol; 2021 Jan; 38(2):13. PubMed ID: 33484353
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Insights into BRCA1/2 Genetic Counseling from Ethnically Diverse Latina Breast Cancer Survivors.
    Rajpal N; Muñoz J; Peshkin BN; Graves KD
    J Genet Couns; 2017 Dec; 26(6):1221-1237. PubMed ID: 28374142
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comprehensive mutation detection of BRCA1/2 genes reveals large genomic rearrangements contribute to hereditary breast and ovarian cancer in Chinese women.
    Cao WM; Zheng YB; Gao Y; Ding XW; Sun Y; Huang Y; Lou CJ; Pan ZW; Peng G; Wang XJ
    BMC Cancer; 2019 Jun; 19(1):551. PubMed ID: 31174498
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sociocultural influences on participation in genetic risk assessment and testing among African American women.
    Hughes C; Fasaye GA; LaSalle VH; Finch C
    Patient Educ Couns; 2003 Oct; 51(2):107-14. PubMed ID: 14572939
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.